Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc-containing regimen in HIV-1
NCT01400412Phase 2Completed
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1). Started Jan 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01400412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400412.